Jump to Main Content

Programs

Product Theaters

A New Treatment Option for Patients with Acute Myeloid Leukemia

Sponsored by Bristol Myers Squibb

Saturday, December 5, 2020, 11:00 a.m. - 12:00 p.m. Pacific time

Speaker:

Michelle Little, PhD
Bristol Myers Squibb

back to top

Study Results from the First and Only Randomized Pivotal Trial in R/R DLBCL

Sponsored by Genentech

Saturday, December 5, 2020, 11:00 a.m. - 12:00 p.m. Pacific time

Speaker:

Lisa Musick, PharmD, BCPS
Genentech

back to top

Introducing BLENREP (belantamab mafodotin-blmf) for Injection, for Intravenous Use

Sponsored by GSK

Saturday, December 5, 2020, 11:00 a.m. - 12:00 p.m. Pacific time

Speaker:

Allison Doherty
GSK

back to top

A Discussion of Efficacy and Safety on a Treatment Option for Adults With Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Sponsored by Pfizer

Saturday, December 5, 2020, 11:00 a.m. - 12:00 p.m. Pacific time

Speaker:

Richa Shah, PharmD
Pfizer

back to top

Advances in the Treatment of aTTP

Sponsored by Sanofi Genzyme

Saturday, December 5, 2020, 11:00 a.m. - 12:00 p.m. Pacific time

Speaker:

Yu Chen Barrett, PhD
Sanofi Genzyme

back to top

NGS Solutions That Help Simplify Your Journey to Answers in Hemato-Oncology Research

Sponsored by Thermo Fisher Scientific

Saturday, December 5, 2020, 11:00 a.m. - 12:00 p.m. Pacific time

Speaker:

Amy Carroll, PhD
Thermo Fisher Scientific

back to top

A Targeted Therapeutic Approach for Relapsed or Refractory FLT3m+ AML Patients

Sponsored by Astellas Pharma US, Inc

Sunday, December 6, 2020, 11:00 a.m. - 12:00 p.m. Pacific time

Speaker:

Ramon V. Tiu, MD
Astellas Pharma US, Inc.

back to top

A Treatment Option for Patients with Myelodysplastic Syndromes

Sponsored by Bristol Myers Squibb

Sunday, December 6, 2020, 11:00 a.m. - 12:00 p.m. Pacific time

Speaker:

Jeffrey A. Jones, MD, MPH
Bristol Myers Squibb

back to top

MONJUVI (tafasitamab-cxix) For Use As Second-line Therapy in Adult Patients with R/R DLBCL, In Combination With Lenalidomide

Sponsored by Incyte Corporation

Sunday, December 6, 2020, 11:00 a.m. - 12:00 p.m. Pacific time

Speaker:

Susan Snodgrass, MD
Incyte Corporation

back to top

Redefining Approaches in Early-Line Multiple Myeloma Treatment

Sponsored by Janssen Biotech, Inc

Sunday, December 6, 2020, 11:00 a.m. - 12:00 p.m. Pacific time

Speaker:

Kathleen Gray, PhD
Janssen Scientific Affairs

back to top

Developing the Future of CAR-T Cell Therapy Today

Sponsored by Novartis Pharmaceuticals

Sunday, December 6, 2020, 11:00 a.m. - 12:00 p.m. Pacific time

Speakers:

Amir Hefni, PhD
Novartis

Carolin Barth, MD
Novartis

back to top

A Treatment Option for Adult Patients With Newly Diagnosed CP Ph+ CML or Patients With CML Resistant/Intolerant to Prior TKI Therapy

Sponsored by Pfizer

Sunday, December 6, 2020, 11:00 a.m. - 12:00 p.m. Pacific time

Speaker:

Jasmeet Anand, PharmD
Pfizer

back to top

An Anti-CD38 Directed Antibody for the Treatment for Appropriate Patients with Relapsed Refractory Multiple Myeloma

Sponsored by Sanofi Genzyme

Sunday, December 6, 2020, 11:00 a.m. - 12:00 p.m. Pacific time

Speaker:

Megan Sell, NP
Sanofi Genzyme

back to top

Exploring Outcomes With Fixed-Duration Treatment in CLL and New Evidence in First-Line AML: Pivotal Clinical Trial Data That Supports Treatment Decisions and Patient Care

Sponsored by Abbvie

Monday, December 7, 2020, 10:30 a.m. - 11:30 a.m. Pacific time

Speaker:

R. Frank Cornell, MD, MS
AbbVie

back to top

clonoSEQ and MRD Assessment in the Management of Lymphoid Malignancies

Sponsored by Adaptive Biotechnologies

Monday, December 7, 2020, 10:30 a.m. - 11:30 a.m. Pacific time

Speaker:

Lanny R. Kirsch, MD
Adaptive Biotechnologies

back to top

PNH: Key Clinical Considerations for a Terminal Complement-Mediated Disease

Sponsored by Alexion Pharmaceuticals

Monday, December 7, 2020, 10:30 a.m. - 11:30 a.m. Pacific time

Speaker:

Anita Hill, MD, PhD
Alexion Pharmaceuticals, Inc.

back to top

Scientific Exploration of Novel Targets for Hematology: A Glimpse into Areas of Research and Development

Sponsored by AstraZeneca

Monday, December 7, 2020, 10:30 a.m. - 11:30 a.m. Pacific time

Speakers:

Katharina Modelska, MD, PhD
FibroGen

Anas Younes, MD
AstraZeneca

Priti Patel, MD
AstraZeneca

Andrew Mortlock, PhD
AstraZeneca

Raoul Tibes, MD, PhD
AstraZeneca

Farzana Walcott
AstraZeneca

back to top

Trust the Experience of a rFVIIa Product Used for a Wide Range of Indications

Sponsored by Novo Nordisk

Monday, December 7, 2020, 10:30 a.m. - 11:30 a.m. Pacific time

Speaker:

Stephanie Seremetis, MD
Novo Nordisk

back to top

IMBRUVICA® in Frontline CLL/SLL: A Case-based Approach

Sponsored by Pharmacyclics LLC, An AbbVie Company

Monday, December 7, 2020, 10:30 a.m. - 11:30 a.m. Pacific time

Speaker:

Imran Khan, MD, PhD
Janssen Biotech, Inc.